???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Helena Cristina Fernandos dos Santos Cabrita Carneiro

Nomes de citação

  • Santos, Helena

Identificadores de autor

Ciência ID
3712-D82D-C799
ORCID iD
0000-0003-1396-8988
Produções

Publicações

Artigo em revista
  1. Helena Santos; Ana R Henriques; Pedro M Machado; Clementina Lopez-Medina; Maxime Dougados; Helena Canhão; Ana M Rodrigues; Fernando Pimentel-Santos. "Determinants of health-related quality of life and global functioning and health in axSpA, pSpA and PsA: results from the ASAS-PerSpA study". Rheumatology (2023): https://doi.org/10.1093/rheumatology/kead503.
    10.1093/rheumatology/kead503
  2. Helena Santos; Ana Rita Henriques; Jaime Branco; Pedro M. Machado; Helena Canhão; Fernando M. Pimentel-Santos; Ana Maria Rodrigues. "Health-related quality of life among spondyloarthritis and chronic low back pain patients: results from a nationwide population-based survey". Quality of Life Research (2023): https://doi.org/10.1007/s11136-022-03274-0.
    10.1007/s11136-022-03274-0
  3. Santos, Helena Carneiro; Henriques, A. R.; Branco, J. C.; Machado, P.; Canhão, H.; Pimentel-Santos, F.; Rodrigues, A. M.. "In a community-based setting spondyloarthritis patients report higher levels of physical disability than chronic low back pain patients-results from EpiReuma.pt". (2023): http://hdl.handle.net/10362/155500.
  4. "Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration". Annals of the Rheumatic Diseases 80 11 (2021): 1410-1418. http://dx.doi.org/10.1136/annrheumdis-2021-220097.
    10.1136/annrheumdis-2021-220097
  5. "Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries". Arthritis Care & Research (2021): http://dx.doi.org/10.1002/acr.24560.
    10.1002/acr.24560
  6. "Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?". Arthritis Research & Therapy 22 1 (2020): http://dx.doi.org/10.1186/s13075-020-02288-8.
    10.1186/s13075-020-02288-8
  7. "Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration". RMD Open 6 3 (2020): e001280-e001280. http://dx.doi.org/10.1136/rmdopen-2020-001280.
    10.1136/rmdopen-2020-001280
  8. Elsa Vieira-Sousa; Mónica Eusébio; Pedro Ávila-Ribeiro; Nikita Khmelinskii; Rita Cruz-Machado; Teresa Martins Rocha; Miguel Bernardes; et al. "Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register". The Journal of Rheumatology (2020): jrheum.181272-jrheum.181272. https://doi.org/10.3899/jrheum.181272.
    10.3899/jrheum.181272
  9. "GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis". Annals of the Rheumatic Diseases 79 4 (2020): 490-498. http://dx.doi.org/10.1136/annrheumdis-2019-216500.
    10.1136/annrheumdis-2019-216500
  10. "Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI". RMD Open 6 1 (2020): e001145-e001145. http://dx.doi.org/10.1136/rmdopen-2019-001145.
    10.1136/rmdopen-2019-001145
  11. "The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy.". Acta reumatologica portuguesa (2018):
  12. "Effectiveness of early adalimumab therapy in psoriatic arthritis patients from Reuma.pt - EARLY PsA.". Acta reumatologica portuguesa (2017):
  13. "The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update.". Acta reumatologica portuguesa (2017):
  14. "Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update.". Acta reumatologica portuguesa (2017):
  15. "Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update.". Acta reumatologica portuguesa (2017):
  16. "Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update.". Acta reumatologica portuguesa (2017):
  17. "Predictors of response to TNF blockers in patients with polyarticular psoriatic arthritis.". Acta reumatologica portuguesa (2017):
  18. "Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort". Medicine 95 51 (2016): e5652-e5652. http://dx.doi.org/10.1097/md.0000000000005652.
    10.1097/md.0000000000005652
  19. "Effect of Comedication With Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study". Arthritis & Rheumatology 68 11 (2016): 2671-2679. http://dx.doi.org/10.1002/art.39772.
    10.1002/art.39772
  20. "Validation of Portuguese-translated computer touch-screen questionnaires in patients with rheumatoid arthritis and spondyloarthritis, compared with paper formats". Rheumatology International 35 12 (2015): 2029-2035. http://dx.doi.org/10.1007/s00296-015-3347-5.
    10.1007/s00296-015-3347-5
  21. "PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE.". Acta reumatologica portuguesa (2015):
  22. "DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt". Rheumatology 54 2 (2015): 286-291. http://dx.doi.org/10.1093/rheumatology/keu313.
    10.1093/rheumatology/keu313
  23. "TRAF1/C5but NotPTPRCVariants Are Potential Predictors of Rheumatoid Arthritis Response to Anti-Tumor Necrosis Factor Therapy". BioMed Research International 2015 (2015): 1-9. http://dx.doi.org/10.1155/2015/490295.
    10.1155/2015/490295
  24. "The Portuguese Society of Rheumatology position paper on the use of biosimilars.". Acta reumatologica portuguesa (2014):
  25. "HLA alleles and HLA-B27 haplotypes associated with susceptibility and severity of ankylosing spondylitis in a Portuguese population". Tissue Antigens 82 6 (2013): 374-379. http://dx.doi.org/10.1111/tan.12238.
    10.1111/tan.12238
  26. "An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group.". Clinical and experimental rheumatology (2013):
  27. "Comparison of the Clinical Expression of Patients with Ankylosing Spondylitis from Europe and Latin America". The Journal of Rheumatology 39 12 (2012): 2315-2320. http://dx.doi.org/10.3899/jrheum.110687.
    10.3899/jrheum.110687
  28. "Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis". Rheumatology 51 11 (2012): 2020-2026. http://dx.doi.org/10.1093/rheumatology/kes184.
    10.1093/rheumatology/kes184
  29. "Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts". Clinical Rheumatology 31 3 (2012): 447-454. http://dx.doi.org/10.1007/s10067-011-1854-7.
    10.1007/s10067-011-1854-7
  30. "Portuguese version of the bath indexes for ankylosing spondylitis patients: a cross-cultural adaptation and validation". Clinical Rheumatology 31 2 (2012): 341-346. http://dx.doi.org/10.1007/s10067-011-1864-5.
    10.1007/s10067-011-1864-5
  31. "Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update.". Acta reumatologica portuguesa (2012):
  32. "ANKHand Susceptibility to and Severity of Ankylosing Spondylitis". The Journal of Rheumatology 39 1 (2012): 131-134. http://dx.doi.org/10.3899/jrheum.110681.
    10.3899/jrheum.110681
  33. "[Practical guide for the use of biological agents in rheumatoid arthritis - December 2011 update].". Acta reumatologica portuguesa (2011):
  34. "Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease.". The Journal of rheumatology (2011): https://doi.org/10.3899/jrheum.101049.
    10.3899/jrheum.101049
  35. "Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects". Arthritis Research & Therapy 13 2 (2011): http://dx.doi.org/10.1186/ar3309.
    10.1186/ar3309
  36. "Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population.". Clinical and experimental rheumatology (2009):
  37. "[Practical guide for the use of biotechnological therapies in rheumatoid arthritis].". Acta reumatologica portuguesa (2009):
  38. "[Perceived pain and weather changes in rheumatic patients].". Acta reumatologica portuguesa (2007):
  39. "A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index.". The Journal of rheumatology (1999):
  40. Santos H; Brophy S; Calin A. "Exercise in ankylosing spondylitis: how much is optimum?". The Journal of rheumatology (1998): http://europepmc.org/abstract/med/9818658.